How can deeper insights into the immunological synapse accelerate immunotherapy discovery? Join our upcoming webinar, Driving Immunotherapy Discovery Through Analyzing the Immunological Synapse, to explore how advanced imaging and single-cell technologies are transforming immunotherapy research. Key Discussion Points: • Cutting-edge imaging techniques for visualizing T-cell interactions • The role of single-cell analysis in biomarker discovery • How these insights are shaping next-generation immunotherapies Gain expert perspectives on the latest innovations in immunology and drug development. Register now- https://hubs.ly/Q03chqvs0 #ImmunoTherapy #Immunology #Biomarker #Webinar
About us
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI. We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.
- Website
-
http://www.evotec.com
External link for Evotec
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Hamburg
- Type
- Public Company
- Specialties
- CNS, Oncology, Pain, Neurosciences, Inflammation, Metabolic disease, Infection, Respiratory diseases, Drug-Discovery, CMC, IND enabling, and Drug Development
Locations
-
Primary
Get directions
Manfred Eigen Campus
Essener Bogen 7
Hamburg, 22419, DE
Employees at Evotec
Updates
-
Another great day at SOT 2025! The Evotec & Cyprotex team is having fantastic conversations at booth #531 and #630, and we'd love for you to join us! Stop by today or tomorrow to connect with our scientific experts, explore our latest innovations, and discuss how we can support your research. Don’t miss this chance before the exhibition wraps up on Wednesday! See you soon! #SOT2025 #ToxExpo #PredictiveToxicology #DrugDiscovery
-
-
Concerned about mutagenic and N-Nitrosamine impurities in your APIs and drug products? Pharmaceutical safety is complex—but with the right expertise, it doesn’t have to be. Our experts help you stay compliant and risk-free. Download our service sheet to learn more, and if you're attending #SOT2025 in Orlando, meet us at booths #531 and #630! https://hubs.ly/Q03cbcgv0 #Pharmaceuticals #DrugSafety #RiskAssessment #MutagenicImpurities #NNitrosamines #RegulatoryCompliance #AnalyticalSupport
-
-
Metabotropic glutamate receptors 2 (mGLuR2) modulate synaptic transmission and neuronal excitability in the central nervous system. Expressed in excitatory neurons, mGluR2 activation can normalize over-activated circuits in the cortico-limbic system. BI-4737, a novel mGluR2 positive allosteric modulator (PAM), originates from a collaboration between Boehringer Ingelheim and Evotec. With BI-4737, you can further investigate glutamate neuronal signaling in disease models. Order now for free on #opnMe: https://hubs.ly/Q03c1NVc0 #OpenScience #Evotec #Boehringer #Neuroscience
-
-
Welcome to SOT 2025! The 64th Annual SOT Meeting & ToxExpo is officially underway, and the Evotec & Cyprotex team is thrilled to be in Orlando! Over the next few days, we look forward to insightful discussions, knowledge sharing, and reconnecting with colleagues across the toxicology community. If you're attending, make sure to attend our exhibitor-hosted sessions on Monday, Tuesday and Wednesday! And our poster presentation on Thursday! Be sure to stop by booth #531 and #630 tomorrow when the exhibition opens. Meet our experts, explore our latest innovations, and discover how our solutions can support your research. 📅 Want to schedule a dedicated meeting and learn more about our presentations? Connect with us here: https://hubs.ly/Q03bGsgS0 #SOT2025 #ToxExpo #PredictiveToxicology #DrugDiscovery
-
-
𝗛𝗼𝘄 𝗶𝘀 𝗔𝗜 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻? A recent Nature article explores how industry leaders are leveraging machine learning, automation, and predictive modeling to reshape the R&D landscape. At Evotec, we are proud to be at the forefront of this transformation, 𝘂𝘁𝗶𝗹𝗶𝘇𝗶𝗻𝗴 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀 𝘁𝗼 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝘁𝗮𝗿𝗴𝗲𝘁 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻, 𝗱𝗿𝘂𝗴 𝗱𝗲𝘀𝗶𝗴𝗻, 𝗮𝗻𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻. By integrating cutting-edge computational approaches with our extensive biological expertise, we are helping to streamline discovery and reduce time-to-market for life-saving therapies. 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗵𝗼𝘄 𝗔𝗜 𝗶𝘀 𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗵𝗲𝗿𝗲- https://hubs.ly/Q039Xm030 #AI #DrugDiscovery #Innovation
-
-
Drug toxicity is a leading cause of failure in development. Early toxicity identification can change that. At Cyprotex, we use advanced in vitro models to identify safety risks early— ensuring the safest compounds reach the clinic. Learn more about our services here: https://hubs.ly/Q03bgjlc0 Get in touch to discuss your project at enquiries@cyprotex.com #theadmetoxspecialists #cyprotex #toxicology
-
Evotec and the renal therapeutic area team 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗮𝗹𝗹 𝗸𝗶𝗱𝗻𝗲𝘆 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 around the world at the occasion of the 𝗪𝗼𝗿𝗹𝗱 𝗞𝗶𝗱𝗻𝗲𝘆 𝗗𝗮𝘆. Together we work on the medicines of tomorrow! 𝗥𝗲𝗮𝗱 𝗼𝘂𝗿 𝘀𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗽𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗵𝗲𝗿𝗲- https://hubs.ly/Q03b7QW70 #TogetherForMedicinesThatMatter #ResearchNeverStops #DrugDiscovery
-
What role do statistical strategies play in optimizing drug product quality? In our second webinar, our senior biostatistician Denise Federico illustrates how advanced statistical methodologies within the QbD framework can transform your processes. Are you equipped with the right tools to succeed in drug development? https://hubs.ly/Q038KVSm0 Gain insights into the application of Design of Experiments (DoE) and if you are interested in the full "Mastering Quality by Design" series you can download all episodes on demand!
-
-
𝗢𝗻-𝗗𝗲𝗺𝗮𝗻𝗱 𝗪𝗲𝗯𝗶𝗻𝗮𝗿: 𝗛𝗶𝘁 𝗙𝗶𝗻𝗱𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 𝗥𝗡𝗔 𝗪𝗼𝗿𝗹𝗱 Keep up-to-date on the latest advances in RNA biology to address challenging targets in drug discovery. Now available on-demand! Watch this insightful webinar presented by Stefan Grimm PhD, VP of the RNA Biology team at Evotec. Hosted by Technology Networks, the webinar explores 𝗰𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗮𝗻𝗱 𝗺𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗲𝗺𝗽𝗹𝗼𝘆𝗲𝗱 𝗯𝘆 𝗘𝘃𝗼𝘁𝗲𝗰 𝗶𝗻 𝗥𝗡𝗔-𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆, with a focus on small molecule approaches. Watch Now: Don't miss this opportunity to 𝗴𝗮𝗶𝗻 𝘃𝗮𝗹𝘂𝗮𝗯𝗹𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗥𝗡𝗔-𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆. Watch on-demand: https://hubs.ly/Q039Vrw90 #RNAtherapeutics #Webinar #DrugDiscovery
-